Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-08-04

Clinical Trial Update: Lipid Peroxidation and Options Antioxidant Therapy for Secondary Lymphedema of the Lower Extremities [Phase 4]

View source ↗

Summary

Phase 4 trial update on lipid peroxidation and antioxidant therapy for secondary lymphedema of the lower extremities has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Ryazan State Medical University | Conditions: Lower Extremity Lymphedema | Phase 4 | Status: COMPLETED